Business & Economics

Featured Image: Lonza, Visp, Switzerland. Courtesy: © 2010 - 2018 Lonza, Visp, Switzerland. Used with permission.

Lonza Expands Bioconjugation Facility for the Commercial Manufacture of Third Antibody-drug Conjugate

Lonza, the Swiss Contract Development and Manufacturing Organization (CDMO), has confirmed the start of expansion to its bioconjugation facility...

Abzena Confirms Successful Technical Transfer of Synaffix’s GlycoConnect™ and HydraSpace™ Technologies

Earlier today Abzena confirmed that it had successfully completed a technology transfer and scalability evaluation using the Synaffix's technologies...
ADC Biotechnology in Deeside, North-Wales, UK. With the availability of a new cleanroom, the company continues its focus on antibody-drug conjugates (ADCs) and developing new process technologies to speed up, simplify and significantly lower the production costs of the latest generation of anticancer blockbuster drugs.

WHP Completes a New State of the Art Cleanroom for ADC Bio

The production of novel antibody-drug conjugates at ADC Biotechnology’s North Wales, United Kingdom, manufacturing plant has been boosted with...
Featured Image: Laboratory Glass works. Courtesy: © 2010 - 2018. Fotolia Used with permission.

SpringWorks and GlaxoSmithKline to Collaborate in the Development of Belantamab Mafodotin

SpringWorks Therapeutics, a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and cancer,...

BioAtla Appoints Eric Sievers, MD, as Chief Medical Officer

BioAtla, a global biotechnology company with operations in San Diego, California, and Beijing, China, focused on the development of...

ImmunoGen to Prioritize Continued Development of Mirvetuximab Soravtansine

Waltham, Massachusetts, based ImmunoGen, expanding field of antibody-drug conjugates (ADCs) with the development of the next generation of targeted...
Board of Directors discussing different issues.

Sutro Biopharma Appoints Former Biogen Idec Executive Connie Matsui as Board Chair

Sutro Biopharma confirmed that the company has appointed Ms. Connie L. Matsui, retired Executive Vice President of Biogen Idec,...

Piramal Invests US $10 Million to Expand and Enhance High Potency API Capability

Piramal Pharma Solutions, a Contract Development and Manufacturing Organization (CDMO), confirmed the Grand Opening of a area of it's...
Photo: Piramal combines individualized service with unparalleled speed and flexibility to manufacture parenteral drug products in liquid and lyophilized dosage forms. Unique mobile isolator technology within FDA-approved sterile manufacturing facility ensures product containment for potent and cytotoxic compounds and radio-labeled products. Photo courtesy: Piramal Pharma Solutions/Coldstream Laboratories, Lexington, Kentucky.

Frost & Sullivan Recognizes Piramal for its End-to-End Integrated Services Across the Entire Drug...

Following a recent analysis of the market of contract development and manufacturing organizations (CDMO), Frost & Sullivan recognized Piramal...

MabPlex International Appoints Dr. Wei Chen as Chief Executive Officer

MabPlex International, a leading and fully integrated global Contract Development and Manufacturing Organization (CDMO) serving the global biopharmaceutical and...